# Vanguard FTSE All-World Ex-U.S. UCITS ETF Accum USD (VXUS)

**Source:** https://fundology.uk/fund/vxus · ISIN IE0009A5ADV9 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, VXUS (Vanguard FTSE All-World Ex-U.S. UCITS ETF Accum USD, ISIN IE0009A5ADV9) closed at £3.70 on the London Stock Exchange.

## Summary

Vanguard FTSE All-World Ex-U.S. UCITS ETF Accum USD is an exchange-traded fund (ETF) from Vanguard, launched in 2026. It tracks the FTSE All-World x US — around 4,000 large and medium-sized companies across developed and emerging markets. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£3.70** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | VXUS |
| ISIN | IE0009A5ADV9 |
| Category | Global shares |
| Type | ETF |
| Provider | Vanguard |
| Tracks | FTSE All-World x US |
| Income | Accumulating |
| Fund size | £59.6m |
| Launched | 2026 |
| Domicile | Ireland |

## Funds tracking the same index

2 funds track FTSE All-World x US, this one included and share classes counted once (01/10/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Vanguard FTSE All-World Ex-U.S. UCITS ETF | — | — | — | — |
| Vanguard FTSE All-World Ex-U.S. UCITS ETF Accum USD (this fund) | — | — | — | — |

Returns are the data vendor’s, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 31/08/2026):

| Holding | Weight |
|---|---|
| Cash and cash equivalents | 6.80% |
| TSMC | 4.15% |
| Samsung Electronics | 2.23% |
| SK hynix | 1.53% |
| ASML | 1.47% |
| Tencent | 0.82% |
| HSBC | 0.80% |
| Roche | 0.72% |
| Novartis | 0.64% |
| Royal Bank of Canada | 0.64% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By sector

Added up from the holdings Vanguard publishes, as of 31/08/2026.

| Sector | Weight |
|---|---|
| Financials | 22.8% |
| Information Technology | 18.1% |
| Industrials | 13.7% |
| Consumer Discretionary | 7.7% |
| Materials | 6.9% |
| Health Care | 6.3% |
| Consumer Staples | 4.7% |
| Energy | 4.3% |
| Other sectors | 8.3% |
| Not classified | 6.8% |

### By country

Added up from the holdings Vanguard publishes, as of 31/08/2026.

| Country | Weight |
|---|---|
| Japan | 14.5% |
| Taiwan | 8.1% |
| United Kingdom | 7.8% |
| Canada | 7.3% |
| Hong Kong | 6.3% |
| South Korea | 6.1% |
| France | 4.8% |
| Switzerland | 4.8% |
| Other countries | 33.2% |
| Not classified | 6.8% |

### By type of asset

Added up from the holdings Vanguard publishes, as of 31/08/2026.

| Type of asset | Weight |
|---|---|
| Equity | 92.8% |
| Cash and money market | 6.8% |

All 2,227 holdings: https://fundology.uk/fund/vxus/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.